| Financial Year |
March 31 2023 |
| Monetary Funds |
814,664,022.59 |
| Held-for-trading Financial Assets |
179,917,447.70 |
| Notes Receivable |
156,125.00 |
| Accounts Receivable |
316,653,558.26 |
| Advances to Suppliers |
24,332,417.10 |
| Other Receivables |
6,889,377.73 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
429,391,781.06 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
75,756,874.03 |
| Other Current Assets |
7,741,820.82 |
| Total Current Assets |
1,855,503,424.29 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
194,247,409.35 |
| Long-term Equity Investment |
432,003,644.47 |
| Investment Properties |
50,803,582.28 |
| Fixed Assetes |
170,325,649.48 |
| Under-construction Projects |
-- |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
72,484,573.57 |
| R&D expenses |
24,666,973.36 |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
5,553,355.80 |
| Deferred Income Tax Assets |
10,767,457.69 |
| Other Non-Current Assets |
11,671,127.66 |
| Sub-Total of Non-Current Assets |
1,140,398,176.53 |
| Total Assets |
2,995,901,600.82 |
| Short-Term Loans |
298,000,000.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
232,797,689.48 |
| Accounts Payable |
191,792,728.15 |
| Accounts Received In Advance |
231,136.93 |
| Employee Compensation Payable |
41,983,472.53 |
| Taxes Payable |
20,583,612.26 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
67,380,218.07 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
4,581,103.41 |
| Other Current Liabilities |
2,834,394.43 |
| Sub-Total of Current Liabilities |
893,284,820.90 |
| Long-term Loans |
45,000,000.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
27,519,916.16 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
98,642,926.03 |
| Total Liabilities |
991,927,746.93 |
| Paid-In Capital(Or Share Stock) |
275,208,300.00 |
| Capital Surplus |
268,362,194.61 |
| Surplus Reserve |
137,986,102.82 |
| LESS:Treasury Stock |
35,665,049.00 |
| Undistributed Profits |
1,282,855,282.37 |
| Minority Stockholder's Interest |
42,964.49 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
2,003,930,889.40 |
| Owner's Equity（Stockholder's Equity） |
2,003,973,853.89 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
2,995,901,600.82 |
